INSMED Inc(INSM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

INSMED Inc (INSM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INSM at 39.4/100 on a 32-signal composite quality model, placing it at rank #2,150 of 2,961 stocks — the bottom half of the AI-ranked universe. INSM scores in the top quartile across revenue growth (96.4), institutional flow (83.2). Areas of concern include balance sheet strength (5.6) and free cash flow (7.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 7.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), INSMED Inc reports quarterly revenue of $425.5M, net income of $-13.2M, free cash flow of $-95.1M. Top institutional holders of INSM by reported 13-F value include FMR, BlackRock, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. INSM trades on the Nasdaq exchange and files with the SEC under CIK 1104506. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INSM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for INSMED Inc directly from SEC EDGAR.